Literature DB >> 23293337

Gaining traction in the treatment of adrenocortical carcinoma.

Lawrence S Kirschner.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23293337      PMCID： PMC3537088          DOI： 10.1210/jc.2012-4034

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

1.  Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.

Authors:  Ricardo J Gonzalez; Suzanne Shapiro; Nicholas Sarlis; Rena Vassilopoulou-Sellin; Nancy D Perrier; Douglas B Evans; Jeffrey E Lee
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

2.  Adjuvant mitotane for adrenocortical cancer--a recurring controversy.

Authors:  Hui Huang; Tito Fojo
Journal:  J Clin Endocrinol Metab       Date:  2008-10       Impact factor: 5.958

3.  Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use.

Authors:  T S Khan; H Imam; C Juhlin; B Skogseid; S Gröndal; S Tibblin; E Wilander; K Oberg; B Eriksson
Journal:  Ann Oncol       Date:  2000-10       Impact factor: 32.976

4.  Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Authors:  Alfredo Berruti; Massimo Terzolo; Paola Sperone; Anna Pia; Silvia Della Casa; David J Gross; Carlo Carnaghi; Paolo Casali; Francesco Porpiglia; Franco Mantero; Giuseppe Reimondo; Alberto Angeli; Luigi Dogliotti
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 5.  Management of patients with adrenal cancer: recommendations of an international consensus conference.

Authors:  D E Schteingart; G M Doherty; P G Gauger; T J Giordano; G D Hammer; M Korobkin; F P Worden
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 6.  Mitotane for adrenocortical carcinoma treatment.

Authors:  Stefanie Hahner; Martin Fassnacht
Journal:  Curr Opin Investig Drugs       Date:  2005-04

7.  Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.

Authors:  A Berruti; M Terzolo; A Pia; A Angeli; L Dogliotti
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

8.  The role of surgery in the management of recurrent adrenocortical carcinoma.

Authors:  Ilknur Erdogan; Timo Deutschbein; Christian Jurowich; Matthias Kroiss; Christina Ronchi; Marcus Quinkler; Jens Waldmann; Holger S Willenberg; Felix Beuschlein; Christian Fottner; Silke Klose; Anke Heidemeier; David Brix; Wiebke Fenske; Stefanie Hahner; Joachim Reibetanz; Bruno Allolio; Martin Fassnacht
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

9.  The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group.

Authors:  F Crucitti; R Bellantone; A Ferrante; M Boscherini; P Crucitti
Journal:  Surgery       Date:  1996-02       Impact factor: 3.982

10.  Adjuvant mitotane treatment for adrenocortical carcinoma.

Authors:  Massimo Terzolo; Alberto Angeli; Martin Fassnacht; Fulvia Daffara; Libuse Tauchmanova; Pier Antonio Conton; Ruth Rossetto; Lisa Buci; Paola Sperone; Erika Grossrubatscher; Giuseppe Reimondo; Enrico Bollito; Mauro Papotti; Wolfgang Saeger; Stefanie Hahner; Ann-Cathrin Koschker; Emanuela Arvat; Bruno Ambrosi; Paola Loli; Gaetano Lombardi; Massimo Mannelli; Paolo Bruzzi; Franco Mantero; Bruno Allolio; Luigi Dogliotti; Alfredo Berruti
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.